Difference between revisions of "Committees"
Jump to navigation
Jump to search
m |
|||
| (34 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
| − | '''[https://tinyurl.com/QIBA- | + | '''[https://tinyurl.com/QIBA-Org-2022-09-20 QIBA Committee Organization Chart (Mar 2023)]''' |
[[Committee Organization]] | [[Committee Organization]] | ||
| Line 8: | Line 8: | ||
:* '''[[CT Coordinating Committee]]''' | :* '''[[CT Coordinating Committee]]''' | ||
| + | ::* [[CT Angiography Biomarker Ctte|CT Angiography Biomarker Committee]] | ||
::* [[CT Volumetry Biomarker Ctte|CT Volumetry Biomarker Committee]] | ::* [[CT Volumetry Biomarker Ctte|CT Volumetry Biomarker Committee]] | ||
| − | |||
::* [[CT Small Lung Nodule Biomarker Ctte|CT Small Lung Nodule Biomarker Committee]] | ::* [[CT Small Lung Nodule Biomarker Ctte|CT Small Lung Nodule Biomarker Committee]] | ||
| − | |||
::* [[Lung Density Biomarker Ctte|Lung Density Biomarker Committee]] | ::* [[Lung Density Biomarker Ctte|Lung Density Biomarker Committee]] | ||
:::* Airway Measurement TF | :::* Airway Measurement TF | ||
| − | |||
| − | |||
| Line 21: | Line 18: | ||
::* [[FMRI tech ctte|fMRI Biomarker Committee]] | ::* [[FMRI tech ctte|fMRI Biomarker Committee]] | ||
::* [[MRE_Biomarker_Ctte|MR Elastography Biomarker Committee]] | ::* [[MRE_Biomarker_Ctte|MR Elastography Biomarker Committee]] | ||
| − | ::* [[PDFF Biomarker Ctte| PDFF (Proton Density Fat Fraction) Biomarker Committee]] | + | ::* [[ISMRM/QIBA PDFF Biomarker Ctte| ISMRM/QIBA PDFF (Proton Density Fat Fraction) Biomarker Committee]] |
::* [[MSK Biomarker Ctte| MSK (Musculoskeletal) Biomarker Committee]] | ::* [[MSK Biomarker Ctte| MSK (Musculoskeletal) Biomarker Committee]] | ||
::* [[DWI MR Biomarker Ctte | Diffusion Weighted Imaging (DWI) MR Biomarker Committee]] | ::* [[DWI MR Biomarker Ctte | Diffusion Weighted Imaging (DWI) MR Biomarker Committee]] | ||
| Line 29: | Line 26: | ||
::* [[EIBIR/QIBA ASL Biomarker Ctte | Arterial Spin Labeling (ASL) Biomarker Committee]] | ::* [[EIBIR/QIBA ASL Biomarker Ctte | Arterial Spin Labeling (ASL) Biomarker Committee]] | ||
::* ''(Dissolved) [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]]'' | ::* ''(Dissolved) [[Perfusion, Diffusion and Flow-MRI tech ctte|PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee]]'' | ||
| − | |||
:* '''[[NM Coordinating Committee]]''' | :* '''[[NM Coordinating Committee]]''' | ||
| Line 36: | Line 32: | ||
:::* FDG-PET UPICT TF | :::* FDG-PET UPICT TF | ||
::* [[PET_Amyloid_Biomarker_Ctte|PET-Amyloid Biomarker Committee]] | ::* [[PET_Amyloid_Biomarker_Ctte|PET-Amyloid Biomarker Committee]] | ||
| + | ::* [[PET Myocardial Blood Flow Biomarker Committee|PET Myocardial Blood Flow Biomarker Committee]] | ||
| + | ::* [[PET Tau Biomarker Committee|PET Tau Biomarker Committee]] | ||
| + | |||
::* [[SPECT Biomarker Ctte|SPECT Biomarker Committee]] | ::* [[SPECT Biomarker Ctte|SPECT Biomarker Committee]] | ||
::* [[TC99m Biomarker Committee|TC99m Biomarker Committee]] | ::* [[TC99m Biomarker Committee|TC99m Biomarker Committee]] | ||
::* [[I-123 Biomarker Committee|I-123 Biomarker Committee]] | ::* [[I-123 Biomarker Committee|I-123 Biomarker Committee]] | ||
| − | |||
:* '''[[US Coordinating Committee]]''' | :* '''[[US Coordinating Committee]]''' | ||
| − | |||
| − | |||
| − | |||
::* [[AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Ctte|AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Committee]] | ::* [[AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Ctte|AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Committee]] | ||
::* [[AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte|AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Committee]] | ::* [[AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Ctte|AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Committee]] | ||
:::* System Dependencies/Phantom Testing/Clinical Validation | :::* System Dependencies/Phantom Testing/Clinical Validation | ||
::* [[Ultrasound CEUS BC|Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC)]] | ::* [[Ultrasound CEUS BC|Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC)]] | ||
| + | ::* [[Ultrasound SWS Biomarker Ctte|Ultrasound SWS Biomarker Committee]] | ||
| + | :::* System Dependencies/Phantom Testing TF | ||
| + | :::* Clinical Applications TF | ||
| − | + | :* '''[[QIBA Sustainability Implementation Committee (QSIC)]]''' | |
:* '''[[Process Coordinating Committee]]''' | :* '''[[Process Coordinating Committee]]''' | ||
:* '''[[Metrology Committee]]''' | :* '''[[Metrology Committee]]''' | ||
| + | :* '''[[Communications Committee]]''' | ||
Latest revision as of 19:07, 2 March 2023
QIBA Committee Organization Chart (Mar 2023)
-
- fMRI Biomarker Committee
- MR Elastography Biomarker Committee
- ISMRM/QIBA PDFF (Proton Density Fat Fraction) Biomarker Committee
- MSK (Musculoskeletal) Biomarker Committee
- Diffusion Weighted Imaging (DWI) MR Biomarker Committee
- Dynamic Contrast Enhanced (DCE) MRI Biomarker Committee
- Dynamic Susceptibility Contrast (DSC) MRI Biomarker Committee
- Diffusion Tensor Imaging (DTI) MRI Biomarker Committee
- Arterial Spin Labeling (ASL) Biomarker Committee
- (Dissolved) PDF-MRI (Perfusion, Diffusion and Flow) Biomarker Committee
-
-
- Profile Compliance TF
- FDG-PET UPICT TF
-
-
- AIUM/QIBA Pulse-Echo Quantitative Ultrasound Biomarker Committee
- AIUM/QIBA Ultrasound Volume Blood Flow Biomarker Committee
- System Dependencies/Phantom Testing/Clinical Validation
- System Dependencies/Phantom Testing TF
- Clinical Applications TF
- (Dissolved) QIBA/RIC ctte and QIDW Oversight Committee
- (Dissolved) Committee on Open Image Archives
See Also
- qiba@rsna.org - Any information and coordination requests
- Committee Template - Template for new Committee Wiki Pages
- Committee Organization - Committee Membership and Responsibilities
- HIT Standards Community Calendar for potential conflicts. Note: it contains multi-day events, not individual tcons etc.